CAYLEY MESTERHEIDE: Open Payments
NPI 1932869674 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 32 payments from 8 companies in 2025. Trend: 2023 $2,086 · 2024 $510 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $204 |
| Otsuka America Pharmaceutical, Inc. | 5 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Alkermes, Inc. | 3 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $81 |
| ABBVIE INC. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Bausch Health US, LLC | 1 | $20 |
Products named: FANAPT, REXULTI, TRINTELLIX, ARISTADA, AUSTEDO XR, VRAYLAR, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
